Novel biomarkers in acute heart failure (Q37890908)

24 August 2017

1 reference

title

Novel biomarkers in acute heart failure (English)

1 reference

Acute decompensated heart failure

24 August 2017

0 references

0 references

1 reference

Marat Yanavitski

1

1 reference

PubMed ID

21681444

24 August 2017

Michael M Givertz

series ordinal

2

1 reference

24 August 2017

1 September 2011

1 reference

Current heart failure reports

24 August 2017

1 reference

24 August 2017

8

1 reference

24 August 2017

206-211

1 reference

24 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-011-0065-5

24 August 2017

0 references

cites work

The expanding national burden of heart failure in the United States: the influence of heart failure in women.

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Identification of serum soluble ST2 receptor as a novel heart failure biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Galectin-3: a novel mediator of heart failure development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Managing acute renal failure in patients with acute decompensated heart failure: the cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Cystatin-C and mortality in elderly persons with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Newer biomarkers in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Prognostic value of circulating chromogranin A levels in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Leptin signaling in the failing and mechanically unloaded human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Serum resistin is associated with high risk in patients with congestive heart failure--a novel link between metabolic signals and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Serum resistin concentrations and risk of new onset heart failure in older persons: the health, aging, and body composition (Health ABC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-011-0065-5

Decrease in serum adiponectin levels in response to treatment predicts good prognosis in acute decompensated heart failure

21 January 2018

1 reference

12 December 2020

Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995

1 reference

12 December 2020

Natriuretic peptides in heart failure: should therapy be guided by BNP levels?

1 reference

12 December 2020

β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure

1 reference

12 December 2020

Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department

1 reference

12 December 2020

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

1 reference

12 December 2020

Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure

1 reference

12 December 2020

Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells

1 reference

12 December 2020

10.1007/S11897-011-0065-5

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21681444